BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro

Journal of Urology

Volumn 169, Issue 2, 2003, Pages 761-766

  Kalsi, Jas S ^a,b   Rees, Rowland W ^a,b   Hobbs, Adrian J ^a,b   Royle, Michael ^a,b   Kell, Phil D ^a,b   Ralph, David J ^a,b   Moncada, Salvador ^a,b   Cellek, Selim ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Sussex Nuffield Hospital   (United Kingdom)

Author keywords

Electric stimulation; Guanylate cyclase; Muscle, smooth; Penis; Relaxation

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; 5 CYCLOPROPYL 2 [1 (2 FLUORO BENZYL) 1H PYRAZOLO[3,4 B]PYRIDINE 3 YL]PYRIMIDIN 4 YLAMINE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; GUANYLATE CYCLASE INHIBITOR; N 2 AMINOETHYL N 2 HYDROXY 2 NITROSOHYDROAZINO 1,2 ETHYLENEDIAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RABBIT;

EID: 0037304589     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64009-8     Document Type: Article

References (21)

1. Andersson, K. E. and Wagner, G.: Physiology of penile erection. Physiol Rev, 75: 191, 1995
2. Andersson, K. E.: Pharmacology of penile erection. Pharmacol Rev, 53: 417, 2001
3. Moncada, S., Higgs, A. and Furchgott, R.: International Union of Pharmacology nomenclature in nitric oxide research. Pharmacol Rev, 49: 137, 1997
4. Hedlund, P., Aszodi, A., Pfeifer, A., Alm, P., Hofmann, F., Ahmad, M. et al: Erectile dysfunction in cyclic GMP-dependent kinase 1-deficient mice. Proc Natl Acad Sci USA, 97: 2349, 2000
5. Krane, R., Brock, G., Eardley, I. et al: Oral non-endocrine treatment. In: First International Consultation in Erectile Dysfunction. Edited by A. Jardin and G. Wagner. Plymouth, United Kingdom: Plymbridge Distributors, p. 243, 2000
6. Rendell, M. S., Rajfer, J., Wicker, P. A. and Smith, M. D.: Sildenafil for the treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA, 281: 421, 1999
7. Cellek, S. and Moncada, S.: Nitrergic neurotransmission in the physiology of penile erection and pathophysiology of erectile dysfunction. In: Nitric Oxide and the Peripheral Nervous System. Edited by N. Toda, S. Moncada, R. Furchgott and E. A. Higgs. London: Portland Press, p. 61, 2000
8. Friebe, A. and Koesling, D.: Mechanism of YC-1 induced activation of soluble guanylyl cyclase. Mol Pharmacol, 53: 123, 1998
9. Wegener, J. W., Gath, I., Forstermann, U. and Nawrath, H.: Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Br J Pharmacol, 122: 1523, 1997
10. Brioni, J. D., Nakane, M., Hsieh, G. C., Moreland, R. B., Kolasa, T. and Sullivan, J. P.: Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction. Int J Impot Res, 14: 8, 2002
11. Liu, S. P., Guh, J. H., Teng, C. M. et al: YC-1, a NO-independent guanylate cyclase stimulator, relaxes rabbit cavernous smooth muscle via increasing intracellular cyclic GMP. Int J Impot Res, suppl., 12: S18, 2000
12. Mizusawa, H., Hedlund, P., Brioni, J. D., Sullivan, J. P. and Andersson, K.-E.: Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat. J Urol, 167: 2276, 2002
13. Nakane, M., Hsieh, G., Miller, L. N., Chang, R., Terranova, M. A., Moreland, R. B. et al: Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1. Int J Impot Res, 14: 121, 2002
14. Friebe, A., Mullershausen, F., Smolenski, A., Walter, U., Schultz, G. and Koesling, D.: YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol, 54: 962, 1998
15. Wohlfart, P., Malinski, T., Ruetten, H., Schindler, U., Linz, W., Schoenafinger, K. et al: Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol, 128: 1316, 1999
16. Stasch, J. P., Becker, E. M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A. et al: NO-independent regulatory site on soluble guanylate cyclase. Nature, 410: 212, 2001
17. Cellek, S. and Moncada, S.: Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: a comparison with other species. Proc Natl Acad Sci USA, 94: 8226, 1997
18. Cellek, S., Kasakov, L. and Moncada, S.: Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase. Br J Pharmacol, 118: 137, 1996
19. Martin, E., Lee, Y. C. and Murad, F.: YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components. Proc Natl Acad Sci USA, 98: 12938, 2001
20. Becker, E. M., Alonso-Alija, C., Apeler, H., Gerzer, R., Minuth, T., Pleibeta, U. et al: NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY41-2272. BMC Pharmacol, 1: 13, 2001
21. Traish, A. M., Park, K., Dhir, V., Kim, N. N., Moreland, R. B. and Goldstein, I.: Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology, 140: 1861, 1999